NPLATE
NPLATE
Approved
DIN Number
02322862
Drug Class
Human
Market Date
Apr 15, 2009
Company
HC
Amgen Canada Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02322862
AIG Number0152535004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
B02BX04 ROMIPLOSTIM
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationSubcutaneous
AHFS Classification20:16.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
ROMIPLOSTIMActive
Strength: 625 MCG / VIAL
Monograph: ROMIPLOSTIM